Veradigm Shares Outstanding 2011-2022 | MDRX
Veradigm shares outstanding from 2011 to 2022. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
|
Veradigm Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2022 | 112 |
| 2021 | 139 |
| 2020 | 159 |
| 2019 | 166 |
| 2018 | 176 |
| 2017 | 181 |
| 2016 | 186 |
| 2015 | 185 |
| 2014 | 180 |
| 2013 | 177 |
| 2012 | 179 |
| 2011 | 191 |
| 2010 | 168 |
|
Veradigm Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2022-12-31 | 112 |
| 2022-09-30 | 129 |
| 2022-06-30 | 119 |
| 2022-03-31 | 139 |
| 2021-12-31 | 139 |
| 2021-09-30 | 131 |
| 2021-06-30 | 145 |
| 2021-03-31 | 149 |
| 2020-12-31 | 159 |
| 2020-09-30 | 161 |
| 2020-06-30 | 163 |
| 2020-03-31 | 162 |
| 2019-12-31 | 166 |
| 2019-09-30 | 166 |
| 2019-06-30 | 167 |
| 2019-03-31 | 170 |
| 2018-12-31 | 176 |
| 2018-09-30 | 175 |
| 2018-06-30 | 179 |
| 2018-03-31 | 180 |
| 2017-12-31 | 181 |
| 2017-09-30 | 181 |
| 2017-06-30 | 181 |
| 2017-03-31 | 181 |
| 2016-12-31 | 186 |
| 2016-09-30 | 186 |
| 2016-06-30 | 187 |
| 2016-03-31 | 191 |
| 2015-12-31 | 185 |
| 2015-09-30 | 189 |
| 2015-06-30 | 182 |
| 2015-03-31 | 181 |
| 2014-12-31 | 180 |
| 2014-09-30 | 180 |
| 2014-06-30 | 180 |
| 2014-03-31 | 179 |
| 2013-12-31 | 177 |
| 2013-09-30 | 178 |
| 2013-06-30 | 178 |
| 2013-03-31 | 174 |
| 2012-12-31 | 179 |
| 2012-09-30 | 173 |
| 2012-06-30 | 185 |
| 2012-03-31 | 193 |
| 2011-12-31 | 191 |
| 2011-09-30 | 191 |
| 2011-06-30 | 193 |
| 2011-03-31 | 193 |
| 2010-12-31 | 187 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.539B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $36.700B | 42.44 |
| Tempus AI (TEM) | United States | $12.562B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $8.471B | 68.91 |
| Doximity (DOCS) | United States | $8.256B | 33.99 |
| IRhythm Technologies (IRTC) | United States | $5.440B | 0.00 |
| Hinge Health (HNGE) | United States | $3.912B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.797B | 62.83 |
| Privia Health (PRVA) | United States | $3.064B | 191.62 |
| Heartflow (HTFL) | United States | $2.255B | 0.00 |
| Omnicell (OMCL) | United States | $1.968B | 40.24 |
| 10x Genomics (TXG) | United States | $1.957B | 0.00 |
| Azenta (AZTA) | United States | $1.623B | 66.60 |
| Enovis (ENOV) | United States | $1.514B | 7.95 |
| Clover Health Investments (CLOV) | United States | $1.395B | 0.00 |
| Schrodinger (SDGR) | United States | $1.330B | 0.00 |
| Phreesia (PHR) | United States | $0.980B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.839B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.760B | 0.00 |
| Claritev (CTEV) | United States | $0.619B | 0.00 |
| CapsoVision (CV) | United States | $0.602B | 0.00 |
| Talkspace (TALK) | United States | $0.581B | 117.00 |
| Standard BioTools (LAB) | United States | $0.558B | 0.00 |
| Evolent Health (EVH) | United States | $0.460B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.413B | 0.00 |
| Carlsmed (CARL) | United States | $0.344B | 0.00 |
| TruBridge (TBRG) | United States | $0.338B | 15.55 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.321B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.280B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.268B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.174B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.161B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.157B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.149B | 0.00 |
| CareCloud (CCLD) | United States | $0.139B | 7.65 |
| Pulmonx (LUNG) | United States | $0.104B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.087B | 0.00 |
| HeartBeam (BEAT) | United States | $0.079B | 0.00 |
| Outset Medical (OM) | United States | $0.076B | 0.00 |
| American Well (AMWL) | United States | $0.075B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.068B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.066B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.044B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.037B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.025B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.014B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| PROFUSA (PFSA) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |